Hi @Mason14 well done
In response to your challenge, I've tried and failed miserably to think of a single reason why, if our PoC trials show efficacy (and reconfirm safety), RAC would be worth less to a well-informed buyer than any of Juno, Loxo or Forty Seven. Of course, they would pay as little as they could get away with.
Love your work.
Speculative M&A Transaction Analysis, page-5
-
- There are more pages in this discussion • 736 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |